{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T11:54:55Z","timestamp":1763726095242},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Cardio Med"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1007\/s11936-006-0018-6","type":"journal-article","created":{"date-parts":[[2007,6,3]],"date-time":"2007-06-03T09:31:18Z","timestamp":1180863078000},"page":"243-250","source":"Crossref","is-referenced-by-count":11,"title":["Vascular cognitive impairment"],"prefix":"10.1007","volume":"8","author":[{"given":"Laura","family":"Pedelty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David L.","family":"Nyenhuis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"18_CR1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0140-6736(74)91496-2","volume":"2","author":"VC Hachinski","year":"1974","unstructured":"Hachinski VC, Lassen NA, Marshall J: Multi-infarct dementia. A cause of mental deterioration in the elderly. Lancet 1974, 2:207\u2013210.","journal-title":"Lancet"},{"key":"18_CR2","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1212\/WNL.56.9.1143","volume":"56","author":"DS Knopman","year":"2001","unstructured":"Knopman DS, DeKoskey ST, Cummings JL, et al.: Practice parameter: diagnosis of dementia (an evidencebased review). Report of the Quality Standards Subcommittee of the Americal Academy of Neurology. Neurology 2001, 56:1143\u20131153. The American Academy of Neurology practice parameter for the diagnosis of dementia.","journal-title":"Neurology"},{"key":"18_CR3","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1056\/NEJM200104123441501","volume":"344","author":"C Wolfson","year":"2001","unstructured":"Wolfson C, Wolfson DB, Asghaian M, et al.: Clinical Progression of Dementia Study Group. A re-evaluation of the duration of survival after the onset of dementia. N Engl J Med 2001, 344:1111\u20131116.","journal-title":"N Engl J Med"},{"key":"18_CR4","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1159\/000026219","volume":"18","author":"K Rockwood","year":"1999","unstructured":"Rockwood K, Howard K, MacKnight C, Darvesh S: Spectrum of disease in vascular cognitive impairment. Neuroepidemiology 1999, 18:248\u2013254.","journal-title":"Neuroepidemiology"},{"issue":"suppl 3","key":"18_CR5","first-page":"S59","volume":"13","author":"K Rockwood","year":"1999","unstructured":"Rockwood K, Bowler JV, Erkinjuntti T, et al.: Subtypes of vascular dementia. Alzheimer Dis Assoc Disord 1999, 13(suppl 3):S59-S65.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"18_CR6","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1111\/j.1532-5415.1998.tb06015.x","volume":"46","author":"D Nyenhuis","year":"1998","unstructured":"Nyenhuis D, Gorelick PB: Vascular dementia: a contemporary review of epidemiology, diagnosis, prevention, and treatment. J Am Geriatr Soc 1998, 46:1437\u20131448.","journal-title":"J Am Geriatr Soc"},{"key":"18_CR7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archneur.1997.00550130019010","volume":"54","author":"K Rockwood","year":"1997","unstructured":"Rockwood K, Ebly E, Hachinski V, Hogan DB: Presence and treatment of vascular risk factors in vascular cognitive impairment. Arch Neurol 1997, 54:33\u201339.","journal-title":"Arch Neurol"},{"issue":"11","key":"18_CR8","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1161\/01.STR.0000143318.70292.47","volume":"35","author":"PB Gorelick","year":"2004","unstructured":"Gorelick PB: Risk factors for dementia and Alzheimer\u2019s disease. Stroke 2004, 35(11suppl 1):2620\u20132622.","journal-title":"Stroke"},{"key":"18_CR9","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.1997.03540340047031","volume":"277","author":"DA Snowden","year":"1997","unstructured":"Snowden DA, Greiner LH, Mortimer JA, et al.: Brain infarction and clinical expression of Alzheimer\u2019s disease. The Nun Study. JAMA 1997, 277:813\u2013817.","journal-title":"JAMA"},{"key":"18_CR10","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1212\/01.WNL.0000118211.78503.F5","volume":"62","author":"JA Schneider","year":"2004","unstructured":"Schneider JA, Wilson RS, Bienias J, et al.: Cerebral infarcts and the likelihood of dementia from Alzheimer disease pathology. Neurology 2004, 62:1148\u20131155. A clinicopathologic study demonstrating increased odds of dementia in patients with cerebral infarctions; absence of a demonstrated interaction between infarcts and Alzheimer pathology suggests additive effects in this study.","journal-title":"Neurology"},{"key":"18_CR11","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1001\/archneur.1990.00530020029011","volume":"51","author":"LR Caplan","year":"1990","unstructured":"Caplan LR, Schmahmann JD, Kase CS, et al.: Caudate infarcts. Arch Neurol 1990, 51:133\u2013143.","journal-title":"Arch Neurol"},{"key":"18_CR12","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/archneur.60.10.1439","volume":"60","author":"JM Anoni","year":"2003","unstructured":"Anoni JM, Khateb A, Gramingna S: Chronic cognitive impairment following laterothalamic tract infarcts: a study of 9 cases. Arch Neurol 2003, 60:1439\u20131443.","journal-title":"Arch Neurol"},{"key":"18_CR13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0022-510X(02)00272-1","volume":"203-204","author":"A Auchus","year":"2002","unstructured":"Auchus A, Chen CP, Sodagar SN, et al.: Single stroke dementia: insights from 12 cases in Singapore. J Neurol Sci 2002, 203-204:85\u201389.","journal-title":"J Neurol Sci"},{"key":"18_CR14","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1001\/archneur.1994.00540220045013","volume":"51","author":"A Corbett","year":"1994","unstructured":"Corbett A, Bennett H, Kos S: Cognitive dysfunction following subcortical stroke. Arch Neurol 1994, 51:999\u20131007.","journal-title":"Arch Neurol"},{"key":"18_CR15","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S1474-4422(02)00190-4","volume":"1","author":"GC Roman","year":"2002","unstructured":"Roman GC, Erkinjuntti T, Wallin A, et al.: Subcortical ischaemic vascular dementia. Lancet Neurol 2002, 1:426\u2013436.","journal-title":"Lancet Neurol"},{"key":"18_CR16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000049144","volume":"13","author":"E Englund","year":"2002","unstructured":"Englund E: Neuropathology of white matter lesions on vascular cognitive impairment. Cerebrovas Dis 2002, 13:11\u201315.","journal-title":"Cerebrovas Dis"},{"key":"18_CR17","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1212\/WNL.45.4.626","volume":"45","author":"LR Caplan","year":"1995","unstructured":"Caplan LR: Binswanger\u2019 disease\u2014revisited. Neurology 1995, 45:626\u2013633.","journal-title":"Neurology"},{"key":"18_CR18","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1161\/01.STR.27.3.408","volume":"7","author":"SE Starkstein","year":"1996","unstructured":"Starkstein SE, Sabe S, Vasquez S, et al.: Neuropsychological, psychiatric, and cerebral blood flow findings in vascular dementia and Alzheimer\u2019s disease. Stroke 1996, 7:408\u2013414.","journal-title":"Stroke"},{"key":"18_CR19","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/WNL.43.2.250","volume":"43","author":"GC Roman","year":"1993","unstructured":"Roman GC, Tatemichi TK, Erkinjuntti T, et al.: Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993, 43:250\u2013260.","journal-title":"Neurology"},{"key":"18_CR20","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1212\/WNL.42.3.473","volume":"42","author":"HC Chui","year":"1992","unstructured":"Chui HC, Victoroff JI, Margolin D, et al.: Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer\u2019s Disease Diagnostic and Treatment Centers. Neurology 1992, 42:473\u2013480.","journal-title":"Neurology"},{"key":"18_CR21","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1994","unstructured":"American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, edn 4. Washington, DC: American Psychiatric Association; 1994.","edition":"edn 4"},{"key":"18_CR22","volume-title":"The ICD-10 Classification of Mental and Behavioural Disorders. Diagnostic Criteria for Research","author":"World Health Organization","year":"1993","unstructured":"World Health Organization: The ICD-10 Classification of Mental and Behavioural Disorders. Diagnostic Criteria for Research. Geneva: World Health Organization; 1993."},{"key":"18_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/oso\/9780192632678.001.0001","volume-title":"Vascular Cognitive Impairment: Preventable Dementia","author":"JV Bowler","year":"2003","unstructured":"Bowler JV, Hachinski V: Current criteria for vascular dementia: a critical appraisal. In Vascular Cognitive Impairment: Preventable Dementia. Edited by Bowler JV, Hachinski V. New York: Oxford University Press; 2003:1\u201311. An overview, including history, specific criteria, and critical review of the four sets of criteria currently used for the diagnosis of vascular dementia."},{"key":"18_CR24","first-page":"437","volume":"47","author":"J Wade","year":"1986","unstructured":"Wade J, Hachinski V: Revised ischemic score for diagnosing multi-infarct dementia. J Clin Psychiatry 1986, 47:437\u2013438.","journal-title":"J Clin Psychiatry"},{"key":"18_CR25","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1046\/j.1468-1331.2001.00332.x","volume":"8","author":"S Maduriera","year":"2001","unstructured":"Maduriera S, Guerreiro M, Ferro JM: Dementia and cognitive impairment three months after stroke. Eur J Neurol 2001, 8:621\u2013627.","journal-title":"Eur J Neurol"},{"key":"18_CR26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/13854040490507145","volume":"18","author":"D Nyenhuis","year":"2004","unstructured":"Nyenhuis D, Gorelick PB, Geenen E, et al.: The pattern of neuropsychological deficits in Vascular Cognitive Impairment, No Dementia (Vascular CIND). Clin Neuropsychol 2004, 18:41\u201349.","journal-title":"Clin Neuropsychol"},{"key":"18_CR27","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1161\/01.CIR.103.1.163","volume":"103","author":"LB Goldstein","year":"2001","unstructured":"Goldstein LB, Adams R, Becker K, et al.: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation 2001, 103:163\u2013182.","journal-title":"Circulation"},{"key":"18_CR28","first-page":"309","volume-title":"Vascular Cognitive Impairment: Preventable Dementia","author":"PB Gorelick","year":"2003","unstructured":"Gorelick PB: Prevention. In Vascular Cognitive Impairment: Preventable Dementia. Edited by Bowler JV, Hachinski V. New York: Oxford University Press; 2003:309\u2013320."},{"key":"18_CR29","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0140-6736(98)03086-4","volume":"352","author":"F Forette","year":"1998","unstructured":"Forette F, Seux ML, Staessen JA, et al.: Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 1998, 352:1347\u20131351.","journal-title":"Lancet"},{"key":"18_CR30","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/archinte.163.9.1069","volume":"163","author":"C Tzourio","year":"2003","unstructured":"Tzourio C, Anderson C, Chapman N, et al.: Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med 2003, 163:1069\u20131075.","journal-title":"Arch Intern Med"},{"key":"18_CR31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1001\/archneur.62.1.23","volume":"62","author":"D Pandey","year":"2005","unstructured":"Pandey D, Gorelick PB: Should statin agents be administered to all patients with ischemic stroke? Arch Neurol 2005, 62:23\u201324.","journal-title":"Arch Neurol"},{"key":"18_CR32","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.clinbiochem.2003.09.004","volume":"37","author":"S Darvesh","year":"2004","unstructured":"Darvesh S, Martin E, Walsh R, Rockwood K: Differential effects of lipid-lowering agents on human cholinesterases. Clin Biochem 2004, 37:42\u201349.","journal-title":"Clin Biochem"},{"key":"18_CR33","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1212\/WNL.53.9.1937","volume":"53","author":"A Ott","year":"1999","unstructured":"Ott A, Stolk RP, van Harskamp F, et al.: Diabetes mellitus and the risk of dementia. The Rotterdam Study. Neurology 1999, 53:1937\u20131942.","journal-title":"Neurology"},{"key":"18_CR34","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1212\/WNL.53.9.1907","volume":"53","author":"S Lovestone","year":"1999","unstructured":"Lovestone S: Diabetes and dementia. Is the brain another site of end-organ damage? Neurology 1999, 53:1907\u20131909.","journal-title":"Neurology"},{"key":"18_CR35","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/oxfordjournals.aje.a009138","volume":"145","author":"DJ Galanis","year":"1997","unstructured":"Galanis DJ, Petrovich H, Launier LJ, et al.: Smoking history in middle age and subsequent cognitive performance in elderly Japanese-American men. The Honolulu-Asia aging study. Am J Epidemiol 1997, 145:507\u2013515.","journal-title":"Am J Epidemiol"},{"key":"18_CR36","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1161\/01.STR.0000120731.88236.33","volume":"35","author":"T Erkinjuntti","year":"2004","unstructured":"Erkinjuntti T, Roman GC, Gauthier S, et al.: Emerging therapies for vascular dementia and vascular cognitive impairment. Stroke 2004, 35:1010\u20131017. A comprehensive overview of vascular dementia and vascular cognitive impairment, including presentation, course, primary and secondary prevention strategies, and pharmacotherapy.","journal-title":"Stroke"},{"key":"18_CR37","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0300-483X(00)00312-7","volume":"153","author":"S Kimura","year":"2000","unstructured":"Kimura S, Saito H, Minami M, et al.: Pathogenesis of vascular dementia in stroke-prone spontaneously hypertensive rats. Toxicology 2000, 153:167\u2013178.","journal-title":"Toxicology"},{"key":"18_CR38","first-page":"163","volume":"5","author":"CG Gottfries","year":"1994","unstructured":"Gottfries CG, Blennow K, Karlssin I, et al.: The neurochemistry of vascular dementia. Dementia 1994, 5:163\u2013167.","journal-title":"Dementia"},{"key":"18_CR39","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jns.2004.09.011","volume":"226","author":"GC Roman","year":"2004","unstructured":"Roman GC: Facts, myths and controversies in vascular dementia. J Neurol Sci 2004, 226:49\u201352. A thoughtful discussion of the history and impact of research criteria for the diagnosis of vascular dementia and the current status of the concept; reviews evidence for a cholinergic deficit in \u201cpure\u201dvascular dementia.","journal-title":"J Neurol Sci"},{"key":"18_CR40","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/01.WNL.0000078943.50032.FC","volume":"61","author":"D Wilkinson","year":"2003","unstructured":"Wilkinson D, Doody R, Helme R, et al.: Donepezil in vascular dementia: a randomized, placebo-controlled study. Neurology 2003, 61:479\u2013486. A randomized study comparing two doses of donepezil versus placebo in 616 patients with probable or possible vascular dementia demonstrating improved cognition and global function in the treatment groups.","journal-title":"Neurology"},{"key":"18_CR41","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1161\/01.STR.0000091396.95360.E1","volume":"34","author":"S Black","year":"2003","unstructured":"Black S, Roman GC, Geldmacher DS, et al.: Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial. Donepezil 307 Vascular Dementia Study Group. Stroke 2003, 34:2320\u20132330. A randomized study comparing donepezil to placebo in 603 patients with probable or possible vascular dementia demonstrating improvement in cognition, global function, and activities of daily living in the treatment groups.","journal-title":"Stroke"},{"key":"18_CR42","first-page":"565","volume":"18","author":"R Moretti","year":"2003","unstructured":"Moretti R, Torre P, Antomello RM, et al.: Rivastigmine in subcortical vascular dementia: a randomized, controlled, open 12-month study in 208 patients. Am J Alzheimers Dis Other Demen 2003, 18:565\u2013572.","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"18_CR43","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0140-6736(02)08267-3","volume":"359","author":"T Erkinjuntti","year":"2002","unstructured":"Erkinjuntti T, Kurz A, Gauthier S, et al.: Efficacy of galantamine in probable vascular dementia and Alzheimer\u2019s disease combined with cerebrovascular disease: a randomised trial. Lancet 2002, 359:1283\u20131290. A randomized placebo-controlled clinical trial of galantamine.","journal-title":"Lancet"},{"key":"18_CR44","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1161\/01.STR.0000020094.08790.49","volume":"33","author":"JM Orgogozo","year":"2002","unstructured":"Orgogozo JM, Rigaud AS, Stoffler A, et al.: Efficacy and safety of memantine in patients with mild to moderate vascular dementia. A randomized, placebo-controlled trial (MMM 300). Stroke 2002, 33:1834\u20131839. A randomized placebo-controlled study of memantine in 288 patients with mild to moderate vascular dementia demonstrating improved cognition and no deterioration versus controls in the treatment group.","journal-title":"Stroke"},{"key":"18_CR45","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00004850-200211000-00005","volume":"17","author":"G Wilcock","year":"2002","unstructured":"Wilcock G, Mobius HJ, Stoffler A: A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500). MMM 500 Group. Int Clin Psychopharmacol 2002, 17:297\u2013305.","journal-title":"Int Clin Psychopharmacol"},{"key":"18_CR46","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1378\/chest.126.3_suppl.429S","volume":"126","author":"DE Singer","year":"2004","unstructured":"Singer DE, Albers GW, Dalen JE, et al.: Antithrombotic therapy in atrial fibrillation: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004, 126:429\u2013456.","journal-title":"Chest"},{"key":"18_CR47","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1532-5415.1989.tb05688.x","volume":"37","author":"JS Meyer","year":"1989","unstructured":"Meyer JS, Rogers RL, McClintic K, et al.: Randomized clinical trial of daily aspirin in multi-infarct dementia. J Am Geriatr Soc 1989, 37:549\u2013555.","journal-title":"J Am Geriatr Soc"},{"key":"18_CR48","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/oxfordjournals.aje.a008801","volume":"14","author":"T Sturmer","year":"1996","unstructured":"Sturmer T, Glynn RJ, Field TS, et al.: Aspirin and cognitive function in the elderly. Am J Epidemiol 1996, 14:683\u2013691.","journal-title":"Am J Epidemiol"},{"key":"18_CR49","doi-asserted-by":"crossref","unstructured":"A randomized trial of anticoagulants versus aspirin in cerebral ischemia. The Stroke Prevention in Reversible Ischemia Study Group [no authors listed]. Ann Neurol 1997, 42:857\u2013865.","DOI":"10.1002\/ana.410420606"},{"issue":"suppl 3","key":"18_CR50","first-page":"S166","volume":"13","author":"B Kittner","year":"1999","unstructured":"Kittner B: Clinical trials of propentofylline in vascular dementia. European\/Canadian Propentifylline Study Group. Alzheimer Dis Assoc Disord 1999, 13(suppl 3):S166-S171.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"18_CR51","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jns.2004.09.014","volume":"226","author":"L Pantoni","year":"2004","unstructured":"Pantoni L: Treatment of vascular dementia: evidence from trials of non-cholinergic drugs. J Neurol Sci 2004, 226:67\u201370. An overview and critical discussion of randomized clinical trials of noncholinergic drugs, including antiplatelet agents, xanthine derivatives, ergot derivatives, vasodilators, and neurotrophic agents.","journal-title":"J Neurol Sci"},{"key":"18_CR52","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","volume":"289","author":"A Chobanian","year":"2003","unstructured":"Chobanian A, Bakris G, Black H, et al.: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 Report. JAMA 2003, 289:2560\u20132572.","journal-title":"JAMA"},{"key":"18_CR53","doi-asserted-by":"crossref","unstructured":"Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) [no authors listed]. JAMA 2001, 285:2586-2-2497.","DOI":"10.1001\/jama.285.19.2486"},{"key":"18_CR54","first-page":"e49","volume":"24","author":"S Grundy","year":"2004","unstructured":"Grundy S, Cleeman J, Merz C, et al.: Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Arterioscler Thromb Vasc Biol 2004, 24:e49-e61.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"suppl 1","key":"18_CR55","doi-asserted-by":"crossref","first-page":"s4","DOI":"10.2337\/diacare.28.suppl_1.S4","volume":"28","author":"American Diabetes Association","year":"2005","unstructured":"American Diabetes Association: Standards of medical care in diabetes. Diabetes Care 2005, 28(suppl 1):s4-s36.","journal-title":"Diabetes Care"}],"container-title":["Current Treatment Options in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-006-0018-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11936-006-0018-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-006-0018-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T19:09:33Z","timestamp":1707937773000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11936-006-0018-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["18"],"URL":"https:\/\/doi.org\/10.1007\/s11936-006-0018-6","relation":{},"ISSN":["1092-8464","1534-3189"],"issn-type":[{"value":"1092-8464","type":"print"},{"value":"1534-3189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,5]]}}}